Lansoprazole

Revision as of 18:12, 27 September 2011 by WikiBot (talk | contribs) (Protected "Lansoprazole": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Synonyms / Brand Names: Lansoprazole, AG 1749, Agopton, Amarin, Aprazol, Bamalite, Biuret Gr, Biuret Reagent Solution, Blason, Compraz, Dakar, Ilsatec, Ketian, Lancid, Lanproton, Lansopep, Lansoprazol, Lansoprazole, Lansoprazolum, Lanston, Lanz, Lanzol-30, Lanzopral, Lanzor, Lasoprol, Limpidex, Mesactol, Monolitum, Ogast, Ogastro, Opiren, Prevacid, Prevacid Iv, Prevacid Solutab, Prevpac, Prezal, Pro Ulco, Promp, Prosogan, Suprecid, Takepron, Ulpax, Zoprol, Zoton

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Dosing and Administration

Each convenience package of PREVACID® NapraPACTM (250, 375 or 500) contains sufficient product for seven days of treatment. Each daily dose consists of one PREVACID 15 mg capsule and two NAPROSYN tablets, either 250 mg, 375 mg or 500 mg. Take the PREVACID capsule and one NAPROSYN tablet in the morning before eating with a glass of water. Take the second NAPROSYN tablet in the evening with a glass of water.

The maximum daily naproxen dose of PREVACID® NapraPACTM (250, 375, or 500) is 1000 mg. Controlled studies for PREVACID® NapraPACTM did not extend beyond 12 weeks. For PREVACID® NapraPACTM (250, 375 or 500), no adjustment of the 15 mg PREVACID component is necessary in patients with renal insufficiency or for the elderly. Dosage adjustment for the NAPROSYN component should be considered for patients with renal insufficiency, liver disease or the elderly



FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.

Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.

Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.

Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information

Trial Resources
Ongoing Trials, Trial Results

Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.

Media Resources
Slides, Video, Images, MP3, Podcasts, etc.

Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.

International Resources
en Español






FDA Package Insert Resources

Indications

Contraindications

Side Effects

Drug Interactions

Precautions

Overdose

Instructions for Administration

How Supplied

Pharmacokinetics and Molecular Data

FDA label

FDA on Lansoprazole

Return to top

Publication Resources

Most Recent Articles on Lansoprazole

Review Articles on Lansoprazole

Articles on Lansoprazole in N Eng J Med, Lancet, BMJ

WikiDoc State of the Art Review

Textbook Information on Lansoprazole

Return to top

Trial Resources

Ongoing Trials with Lansoprazole at Clinical Trials.gov

Trial Results with Lansoprazole

Return to top

Guidelines & Evidence Based Medicine Resources

US National Guidelines Clearinghouse on Lansoprazole

Cochrane Collaboration on Lansoprazole

Cost Effectiveness of Lansoprazole

Return to top

Media Resources

Powerpoint Slides on Lansoprazole

Images of Lansoprazole

Podcasts & MP3s on Lansoprazole

Videos on Lansoprazole

Return to top

Patient Resources

Patient Information from National Library of Medicine

Patient Resources on Lansoprazole

Discussion Groups on Lansoprazole

Patient Handouts on Lansoprazole

Blogs on Lansoprazole

Lansoprazole in the News

Lansoprazole in the Marketplace

Return to top

International Resources

Lansoprazole en Español

Return to top


Adapted from the FDA Package Insert.